• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    David Schnur Associates Adds ERI Group to Its Network of Partners

    BlackHägen Design Promotes Jeff Morang to Director of Human Factors Engineering

    Great Speech Wins First Place at ATA 2023 Innovator’s Challenge

    FDA Clears Magstim Transcranial Magnetic Stimulation for OCD

    3D Virtual Simulation Helps Medical Students Diagnose, Treat Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'

    Discussing Matters of Substance in Medtech Materials

    Medical Device Testers Are Caught Up in a Whirlwind

    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    CR-SOP Neurotechnology Helps to Achieve ‘Sound’ Sleep

    Inside the Hospital Value Analysis Committee

    Face Time: Why Getting Engineers Out of the Lab Is Good for Business

    Common Paratubing Pitfalls and How to Avoid Them

    During Times of Uncertainty, Create Business Value with an Optimized Workforce
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Forefront Medical Technology

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment

    Sourcing Silicone Parts: Injection Mold or 3D Print?

    Cybersecurity in Healthcare: Getting on the Right Track
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Forefront Medical Technology

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    New Program with Payors Aims to Accelerate Patient Access to Medical Devices

    The Parallel Review Program lets FDA and CMS simultaneously review clinical evidence supporting both approval and coverage.

    Scott Gottlieb, M.D., Commissioner, U.S. Food and Drug Administration09.05.18
    Advancing the public health means helping to make sure patients have access to safe, effective medical products. Access is a matter of public health. And our commitments to patients don’t stop at the time of a product’s approval. We take many steps to make sure products can be safely accessed in the post-market setting, and that new innovations continue to deliver their anticipated benefits. We actively monitor for safety findings in the post-approval period. We have updated labeling to provide modern guidance to providers and patients. And as part of our dedication to the promotion of public health, we also look for opportunities to help advance wider access to safe and effective innovations.
     
    Patients may not have access to an FDA approved or cleared device in the absence of adequate coverage. So, the FDA recognizes the importance of working collaboratively with the payor community to streamline the path from FDA market authorization to payor coverage and reimbursement.
     
    Over the past few years, we’ve sought creative solutions to decreasing the gap between the FDA’s decision to advance a product to the market and the time it takes both public (e.g., Medicare, Medicaid) and private payors to determine whether and how they will provide coverage.
     
    Today, we’re announcing some new steps to help narrow this chasm by expanding our work with private payors. First, some history on the efforts that we’ve undertaken to date:
    Previously, one of our early and most successful efforts was the creation of the Parallel Review Program. This program was piloted in 2011 with the Centers for Medicare and Medicaid Services (CMS). It was fully adopted in 2016 after proving to be a valuable mechanism for decreasing the time between the FDA’s approval of a pre-market medical device application and CMS national coverage determination.
     
    The Parallel Review Program enables the FDA and CMS to review, at the same time, the clinical evidence that supports both the approval and coverage of a new medical device. Traditionally, the FDA reviews the relevant non-clinical and clinical evidence first and then issues a regulatory decision. Then, after the FDA approves the device, payor organizations like CMS would begin reviewing the relevant clinical evidence. As one might expect, a parallel review process is much more efficient than a serial review process.
     
    Through the Parallel Review Program, we saw that earlier opportunities for collaboration during the process were critical for success. Manufacturers who design and conduct the clinical trials benefit from early feedback from the FDA and CMS as they develop their plans to conduct clinical investigations to gather valuable clinical evidence. Including CMS in the Pre-Submission meeting can allow manufacturers to obtain feedback from both the FDA and CMS while planning a clinical trial. Manufacturers can then factor this information into their design of a pivotal clinical trial. The development program can be structured to meet the needs of both regulators like the FDA and payors. Such an approach has many advantages in addition to timelier access, and lower costs. For example, if medical device manufacturers have a better understanding of the clinical evidence needed by both agencies, then manufacturers might consider ways to collect all the necessary evidence through clinical programs that are more efficient. They may be able to reduce the size and duration of trials, and expose fewer patients to an experimental product.
     
    To date, the FDA has received more than 75 inquiries into the process and 36 formal applications to participate in Parallel Review. The FDA treats these inquiries and applications as confidential. We don’t disclose a manufacturer’s participation in the program. However, the company may choose to make its participation public.
     
    While CMS covers a significant number of Americans, private payor organizations also play an important role in evaluating clinical evidence and making coverage decisions for patients in the U.S. Building on the lessons learned through the Parallel Review Program, in 2016 the FDA launched a new program aimed at engaging private payors and Health Technology Assessment groups through the Private Payor Program.
     
    The Private Payor Program is a voluntary opportunity for manufacturers to receive feedback from the FDA and other non-governmental health technology assessors/payors on what’s needed in order to develop a more efficient evidence generation strategy during the FDA pre-submission meeting.
     
    Today, we are announcing that CareFirst BlueCross BlueShield and United Health Group have joined the FDA’s growing list of private payors available to participate in medical device manufacturer pre-submission meetings.
     
    In addition to these two new participants, there are currently six other payor/health technology assessment organizations participating in the program, including BlueCross BlueShield Association, Duke Evidence Synthesis Group, ECRI Institute, Humana, Kaiser Permanente, and the National Institute for Health and Care Excellence (NICE).
     
    By facilitating communications between device makers and payors, the FDA hopes to shorten the time between FDA approval and coverage decisions. This can be particularly beneficial for manufacturers creating new and innovative devices who also need to secure coverage of their devices by payors.
     
    The process of acquiring clearance or approval from the FDA, and then coverage from a payor, can take several years to achieve. This delay can be challenging for patients, particularly those with limited alternatives for diagnosing and treating potentially serious medical conditions. In some cases, the long timeframe between those decisions may also have an adverse consequence on smaller medical device companies, which may be unable to sustain themselves for an extended duration of time with limited revenue streams. These challenges are significant. And they’re driving our continued efforts to identify new ways to improve the speed and efficiency of our regulatory review process and coverage decisions.
     
    To date, there have been 10 engagements between private payors or Health Technology Assessment (HTA) groups and manufacturers. This includes four pre-submission meetings.
     
    The program continues to gain momentum. We’re receiving new inquiries weekly.
     
    The FDA believes that early engagement with manufacturers and payors during the planning phase of medical device clinical trials will expedite patient access to high quality, safe, and effective medical devices. We appreciate the complexity of the process of achieving patient access to new medical devices. And we recognize that a variety of stakeholders have important roles in that process.
     
    In streamlining the process, our goal is to improve coordination so that access to approved products can be achieved without unnecessary delay. To that end, we continue to support and encourage the collection of clinical evidence that’ll not only support regulatory decisions but also inform coverage decisions—ultimately providing an opportunity for more timely patient access to new technologies.
     
    We’re all beneficiaries of this collaborative model to ensure the availability of safe, timely, effective and affordable health care options. For patients, it can mean earlier access to safe, effective, innovative technologies. And for payors, it can mean learning about new technologies beyond their current horizon scanning, and being able to provide suggestions about what data and analyses would be useful for evaluation, gaining insight and increased understanding of the FDA review process.
     
    For manufacturers, it’s early engagement of payors in discussions about evidentiary needs, being able to consider and address coverage-related issues earlier in the process, and gaining the potential for earlier reimbursement through earlier engagement with payors. For the FDA, it’s improving public health by facilitating more efficient patient access to innovative, safe, and effective medical devices.
     
    As our work continues to grow in scope and complexity, so must our efforts to collaborate on innovative and streamlined approaches to finding the best ways to serve the American public.
     
    I hope that by sharing this insight and vision, we inspire other organizations and manufacturers to come together early in the process so we can more effectively identify opportunities, challenges and approaches to access, and maximize our collective resources to get beneficial devices to patients.
     
    This blog originally appeared in FDA Voice.
    Related Searches
    • design
    • health
    • clinical trials
    • company
    Suggested For You
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    CVRx Completes First Procedure With Ultrasound-Guided Implant Approach CVRx Completes First Procedure With Ultrasound-Guided Implant Approach
    Stanislav Glezer Joins Inogen as Chief Medical Officer Stanislav Glezer Joins Inogen as Chief Medical Officer
    Satellite Healthcare, Outset Medical Partner to Boost Home Dialysis Satellite Healthcare, Outset Medical Partner to Boost Home Dialysis
    Successful First Human Use of Foldex Successful First Human Use of Foldex's Biopolymer Mitral Heart Valve
    Metal Injection Molding and Metal 3D Printing Examination Metal Injection Molding and Metal 3D Printing Examination
    Integra Highlights Data from Diabetic Foot Ulcer Study Integra Highlights Data from Diabetic Foot Ulcer Study
    Endologix Launches ALTO Abdominal Stent Graft System in Canada, Argentina Endologix Launches ALTO Abdominal Stent Graft System in Canada, Argentina
    Expanded FDA Approval for Medtronic Expanded FDA Approval for Medtronic's Arctic Front Cryoablation Catheter
    Pear Therapeutics to Become Public Company Pear Therapeutics to Become Public Company
    CE Mark Granted for Biostable Science CE Mark Granted for Biostable Science's HAART 200 Device
    GE Healthcare, ACC Team Up to Advance AI in Cardiac Care GE Healthcare, ACC Team Up to Advance AI in Cardiac Care
    Will Recent Changes in CMS Rules Sink Us? Will Recent Changes in CMS Rules Sink Us?
    Leveraging Your Outsourcing Relationship for Success—A Medtech Makers Q&A Leveraging Your Outsourcing Relationship for Success—A Medtech Makers Q&A
    Five Tips to Protect IP While Working with a Freelancer Five Tips to Protect IP While Working with a Freelancer

    Related Breaking News

    • Quanta Raises $245 Million in Series D Funding Round

      Quanta Raises $245 Million in Series D Funding Round

      Money will help accelerate the commercialization of the company's SC+ Portable Hemodialysis System.
      Business Wire 09.10.21

    • Cardiovascular
      CVRx Completes First Procedure With Ultrasound-Guided Implant Approach

      CVRx Completes First Procedure With Ultrasound-Guided Implant Approach

      The new approach is the latest advancement in Barostim for treating heart failure symptoms.
      Globe Newswire 08.26.21

    • Stanislav Glezer Joins Inogen as Chief Medical Officer

      Stanislav Glezer Joins Inogen as Chief Medical Officer

      New hire most recently worked for Becton, Dickinson and Company as worldwide vice president of Medical Affairs for Diabetes Care.
      Business Wire 08.24.21


    • Satellite Healthcare, Outset Medical Partner to Boost Home Dialysis

      Satellite Healthcare, Outset Medical Partner to Boost Home Dialysis

      Outset Medical’s Tablo Hemodialysis System selected as the tech to further enable Satellite Healthcare’s efforts to drive home hemodialysis growth.
      Business Wire 08.13.21

    • Cardiovascular
      Successful First Human Use of Foldex

      Successful First Human Use of Foldex's Biopolymer Mitral Heart Valve

      Second product from Tria Biopolymer Valve portfolio to move into human study.
      Business Wire 07.30.21

    Loading, Please Wait..

    Trending
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • The Future Of Biomedical Engineering Advancements
    • A New Approach To Post-Market Surveillance
    • Philips Names New Supervisory Board Chairman
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    Breaking News
    • David Schnur Associates Adds ERI Group to Its Network of Partners
    • BlackHägen Design Promotes Jeff Morang to Director of Human Factors Engineering
    • Great Speech Wins First Place at ATA 2023 Innovator’s Challenge
    • FDA Clears Magstim Transcranial Magnetic Stimulation for OCD
    • 3D Virtual Simulation Helps Medical Students Diagnose, Treat Patients
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    House Reps Try Again to Regulate CBD and Other Hemp Derivatives as Dietary Ingredients
    'What’s Up With Supps' Event at Expo West Raises Over $8,000 for Vitamin Angels
    IRI and NPD Rebrand as Circana Following Merger
    Coatings World

    Latest Breaking News From Coatings World

    BASF Invests in Expansion of Polymer Dispersions Plant in Daya Bay, China
    Stahl Completes Acquisition of ICP Industrial Solutions Group
    Interpon Powder Coatings on Dubai’s Latest Luxury Hotel ​
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    David Schnur Associates Adds ERI Group to Its Network of Partners
    BlackHägen Design Promotes Jeff Morang to Director of Human Factors Engineering
    Great Speech Wins First Place at ATA 2023 Innovator’s Challenge
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioNTech, OncoC4 Partner to Develop mAb Candidate ONC-392 in Cancer
    FLAMMA to Invest $200M Over the Next Three Years
    Pii Forms New Leadership Team
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Selena Gomez Becomes Most-Followed Woman on Instagram
    Former Estée Lauder Execs Join Stila Cosmetics' Advisory Board
    Ole Henriksen's Eye Stick is Made from Limestone
    Happi

    Latest Breaking News From Happi

    L’Oréal Invests in Geno-led Venture for Biotech Ingredients
    Saltair Adds Santal Bloom Body Oil to Personal Care Collection
    Fredericksburg Farms Recalls Scented Candles with Glass Lids
    Ink World

    Latest Breaking News From Ink World

    Chris Scully Takes Over Koenig & Bauer UK
    Kodak Reports 4Q, Full-Year 2022 Financial Results
    Fujifilm Releases Uvijet HZ Thermoforming Ink for Acuity Prime Series
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Imageworx showcasing Lombardi presses at new Innovation Center
    Schreiner PrinTrust supplies RFID-enabled labels for seventhings
    McDonald’s to publish report on reusable packaging
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: TerraCycle Launches Diaper Program, Ahlstrom to Divest or Shutter Stenay Plant & More
    Mativ Names CFO
    Indorama Ventures, Polymateria Partner on Biotransformation Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Study Highlights the Positive Clinical Outcomes of Medacta’s MySpine System
    NuVasive Receives Expanded Indications for Precice Limb Lengthening Solution
    Alex Jahangir Receives Highest Leadership Award From AAOS
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    LG Display’s 65-Inch OLED TV Panel Receives Carbon Footprint Certification
    Overcoming the Four Greatest MaaS Ticketing Challenges
    Jabil Posts Second Quarter 2023 Results

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login